日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Advancing Daptomycin Precision Dosing Through Evaluation of Published Population Pharmacokinetic Models and Development of a Dosing Tool

通过评估已发表的群体药代动力学模型和开发给药工具，推进达托霉素的精准给药

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S581874
Xie, Xi; Qian, Cheng; Luque, Sonia; Liu, Li; Chen, Jiayu; Mendoza, Carla Comajuan; Sorli, Luisa; Yuan, Huamin; Ma, Chen; Ren, Lin; Xu, Nuo; Ju, Gehang; Zhu, Xiao; Liu, Xin
发表日期：2026
文献求助 收藏

Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study

卡泊芬净在危重症中国儿童中的群体药代动力学：一项前瞻性观察研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01277-25
Xu, Nuo; Shi, Yufei; Ju, Gehang; Liu, Xin; Yan, Gangfeng; Zheng, Yi; Hou, Shuyu; Xiang, Xiaoqiang; Lu, Guoping; Ouyang, Dongsheng; Zhu, Xiao; Wang, Yixue
发表日期：2026
文献求助 收藏

Regulatory effects of carbon and nitrogen nutrition on lipid accumulation by Yarrowia lipolytica cultivated with high-concentration volatile fatty acids

碳氮营养对高浓度挥发性脂肪酸培养的解脂耶氏酵母脂质积累的调节作用

期刊:Bioprocess and Biosystems Engineering
影响因子:3.6
doi:10.1007/s00449-025-03263-w
Wang, Xuemei; Yuan, Gehang; Li, Meiyan; Sun, Shushuang; Cheng, Shikun; Campos, Luiza C; Li, Zifu
代谢
发表日期：2026
文献求助 收藏

Bridging Literature and Real-World Evidence: External Evaluation and Development of Fluoxetine Population Pharmacokinetics Model

连接文献与真实世界证据：氟西汀群体药代动力学模型的外部评价与开发

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17121516
Han, Bing; Xu, Nuo; Ma, Chen; Ju, Gehang; Xi, Xie; Qian, Cheng; Guo, Nan; Liu, Xin; Zhu, Xiao; Li, Cong; Liu, Li
发表日期：2025
文献求助 收藏

Optimized Sampling Strategies for Isoniazid in East Asian Pediatric Populations Using Population Pharmacokinetics-Informed Approaches

基于群体药代动力学的东亚儿科人群异烟肼优化采样策略

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S503987
Ju, Gehang; Liu, Xin; Peng, Yeheng; Yang, Wenyu; Xu, Nuo; He, Qingfeng; Zhang, Chenchen; Chen, Lulu; Yang, Nan; Zhang, Gufen; Li, Chao; Su, Pan; Zhu, Xiao; Ouyang, Dongsheng
发表日期：2025
文献求助 收藏

Investigation of the ABCB1 Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic Analysis

ABCB1基因多态性及食物对中国人群阿伐曲波帕药代动力学影响的研究：一项群体药代动力学/药效学分析

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph18060903
Liu, Xin; Chen, Lulu; Ju, Gehang; Li, Chao; Liu, Bijue; Fei, Yunzhou; Wang, Xintong; Gao, Yang; He, Qingfeng; Zhu, Xiao; Ouyang, Dongsheng
ABCB1
发表日期：2025
文献求助 收藏

Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy

利福平参数化群体药代动力学模型库：基于模型的个体化治疗

期刊:Clinical Pharmacology-Advances and Applications
影响因子:2.5
doi:10.2147/CPAA.S502272
Ju, Gehang; Liu, Xin; Gu, Meng; Chen, Lulu; Wang, Xintong; Li, Chao; Yang, Nan; Zhang, Gufen; Zhang, Chenchen; Zhu, Xiao; He, Qingfeng; Ouyang, Dongsheng
发表日期：2025
文献求助 收藏

Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository

基于模型的异烟肼精准给药：参数化群体药代动力学模型库

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S434919
Ju, Gehang; Liu, Xin; Yang, Wenyu; Xu, Nuo; Chen, Lulu; Zhang, Chenchen; He, Qingfeng; Zhu, Xiao; Ouyang, Dongsheng
发表日期：2024
文献求助 收藏

External Validation of the Population Pharmacokinetic Models of Amisulpride and Remedial Strategies for Delayed or Missed Doses

阿米舒必利群体药代动力学模型的外部验证及延迟或漏服药物的补救策略

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S469149
Yan, Desheng; Ju, Gehang; Liu, Xin; Shao, Qing; Zhang, Yan; Wang, Na; Yan, Keyu
发表日期：2024
文献求助 收藏

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method

艾司西酞普兰个体化给药：一种基于群体药代动力学数据库的方法

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S425654
Liu, Xin; Ju, Gehang; Yang, Wenyu; Chen, Lulu; Xu, Nuo; He, Qingfeng; Zhu, Xiao; Ouyang, Dongsheng
发表日期：2023
文献求助 收藏